MoneyWorks4Me

Marksans Pharma - Quaterly Results

12 Aug 2025 Evaluate
The sales figure stood at Rs. 3197.34 millions for the June 2025 quarter. The mentioned figure indicates a growth of about 25.62% as compared to Rs. 2545.27 millions during the year-ago period.Net profit for the quarter ended June 2025 increased significantly by 50.10% to Rs. 480.56 millions from Rs. 320.15 millions.The company reported a good operating profit of 720.64 millions compared to 494.18 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3197.34 2545.27 25.62 3197.34 2545.27 25.62 11743.74 8532.73 37.63
Other Income 20.10 81.52 -75.34 20.10 81.52 -75.34 698.34 620.73 12.50
PBIDT 720.64 494.18 45.83 720.64 494.18 45.83 2738.85 2020.08 35.58
Interest 3.02 2.83 6.71 3.02 2.83 6.71 11.74 9.88 18.83
PBDT 717.62 491.35 46.05 717.62 491.35 46.05 2727.11 2010.20 35.66
Depreciation 81.88 68.36 19.78 81.88 68.36 19.78 294.52 291.28 1.11
PBT 635.74 422.99 50.30 635.74 422.99 50.30 2432.59 1718.92 41.52
TAX 155.18 102.84 50.89 155.18 102.84 50.89 549.87 381.34 44.19
Deferred Tax 9.80 -0.74 -1424.32 9.80 -0.74 -1424.32 28.43 6.78 319.32
PAT 480.56 320.15 50.10 480.56 320.15 50.10 1882.72 1337.58 40.76
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 453.16 0.00
PBIDTM(%) 22.54 19.42 16.09 22.54 19.42 16.09 23.32 23.67 -1.49
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..